Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1671 1672 1675
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18549722 | SUBUNIT VACCINES WITH DINUCLEOTIDE-LOADED HYDROGEL ADJUVANT | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18175852 | MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18035809 | ENGINEERED PROTEIN FOR RAPID, EFFICIENT CAPTURE OF PATHOGEN-SPECIFIC ANTIBODIES | Final Rejection | Massachusetts Institute of Technology |
| 18277879 | NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME | Final Rejection | CJ CheilJedang Corporation |
| 18686564 | MULTIVALENT VIRAL PARTICLES | Non-Final OA | CORNELL UNIVERSITY |
| 18553124 | Peptide of Norovirus Origin, Polynucleotide, Antibody, Composition, Method for Identifying Neutralizing Epitope for Norovirus | Non-Final OA | Denka Company Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy